Best possible serotype coverage in the respective age group

The disease burden of pneumococcal infections is highest in <5-year-old children and ≥65-year-old adults, as well as in the presence of certain comorbidities and in immunocompromised individuals. In Switzerland, there are around 1000 serious pneumococcal infections every year – mostly pneumonia, less frequently blood poisoning or meningitis. In the current EKIF-FOPH vaccination recommendations, PCV13 or PCV15 is considered equivalent for <5-year-olds, whereas a conjugate vaccine with a higher valency than PCV13 (i.e. PCV15 or PCV20) is recommended for adults.